Acquisition

UBS sees dozens of its Southeast advisors on Barron's 2026 list, signaling a strategic victory in a key growth market. What does this mean for clients?

An amended deal with Tasly positions AP Biosciences to license its innovative bispecific cancer therapy to global pharma giants, targeting a lucrative market.

Aurinia Pharmaceuticals' deal for Kezar Life Sciences hinges on zetomipzomib, a promising but risky drug poised to tackle a rare autoimmune liver disease.

The massive C$5.15 billion deal transforming Plains into a crude oil pure-play and Keyera into an NGL giant faces a delay amid a Competition Bureau review.

With a new president and a recent acquisition, Once Upon a Coconut is scaling rapidly, leveraging deep industry experience to challenge beverage giants.

Fancamp Exploration is splitting into two companies, creating a stable royalty firm and a high-stakes gold explorer, Goldera, to unlock shareholder value.

Alex Oberberg joins S4 Capital's Monks as EMEA CRO, tasked with scaling AI systems and unifying marketing in a play for regional dominance.

Boston-based Rockpoint deepens its Sun Belt bet, acquiring a 279,507 sq ft portfolio in Charlotte and Raleigh amid a fierce industrial real estate boom.

Following rapid growth and a private equity acquisition, DAS Health appoints Lee Horner to navigate healthcare's complex digital and cybersecurity challenges.

PMGC Holdings touts major acquisitions and a promising biotech pipeline, but a look at its financials reveals a high-stakes bet on future growth.

Universal Plant Services acquires engineering firm MSI, aiming to merge advanced diagnostics with field execution for a powerful end-to-end industrial solution.

Franklin BSP Realty Trust's major debt deal shows strong investor faith in its multifamily strategy, a bright spot in a cautious real estate market.

The acquisition deepens Boardwalk's control of the natural gas value chain, while Spire pivots to its core utility business amid a dynamic energy market.

Analyses reveal the EPA allows pesticides with high cancer risks on the market without warning labels, raising major public health and legal questions.

With a record $300M prize pot, the new Premier Jumping League aims to revolutionize equestrian sport, promising a sustainable future for its top athletes.

As Guild Garage adds two Washington firms, its own recent sale to a private equity giant reveals a massive consolidation play in the home services industry.

Global CRO ChemPartner launches a new research site in Kent's Discovery Park, a major strategic push to accelerate drug development for European clients.

With €22.3B in revenue, Giovanni Ferrero's unified 3F's Holding is aggressively expanding into snacks, cereals, and ice cream. Here's the strategy.

A new report reveals a major shift in cybercrime, with attackers now preferring stolen credentials over hacking to breach corporate networks.

Equasens reports a 9.1% revenue jump, driven by AI investment and key acquisitions, as the company navigates a major leadership change and market shifts.